---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-104028"
form_type: "8-K"
ticker: "TTRX"
cik: "0002023016"
company_name: "Turn Therapeutics Inc."
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:26:21.725594+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Turn Therapeutics enters global supply, development, and license agreement with Medline

## Summary
- Agreement covers development, manufacture, and commercialization of products using Turn's PermaFusion delivery platform.
- Medline is the largest provider of medical-surgical products and supply chain solutions in the U.S.
- Financial terms, product categories, and development timelines remain confidential per agreement terms.
- CEO Bradley Burnam calls partnership a 'transformative milestone' to accelerate entry into professional and consumer markets.

## SEC filing metadata
- accession: 0001104659-25-104028
- form_type: 8-K
- ticker: TTRX
- cik: 0002023016
- company_name: Turn Therapeutics Inc.
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2023016/000110465925104028/0001104659-25-104028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2023016/000110465925104028/tm2529778d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-104028
- JSON: https://secwatch.observer/filing/0001104659-25-104028.json
- Plain text: https://secwatch.observer/filing/0001104659-25-104028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.